Activation of the phosphatidylinositol-4,5-biphosphate 3-kinase (PI3K)/AKT/mechanistic target of rapamycin (mTOR) signaling pathway has been described in many malignancies, including HCC, with its role in promoting persistent HCV infection also reported [77]. Here, MTOR is linked to hepatocellular carcinoma.